Share this post on:

Methylprednisolone

Methylprednisolone is a synthetic glucocorticoid that displays anti-inflammatory and immunosuppressive activities. In vitro, methylprednisolone decreases survival of activated CD4+ T cells. In glioblastoma cells, this compound inhibits oxidative stress-induced apoptosis. Additionally, methylprednisolone decreases infiltration of immune cells and suppresses release of inflammatory cytokines in animal models of inflammation.

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18944617

Cas No.

83-43-2

Purity

≥96%

Formula

C22H30O5

Formula Wt.

374.47

Chemical Name

(6α,11β)-11,17,21-Trihydroxy-6-methylpregna-1,4- diene-3,20-dione

IUPAC Name

(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one

Synonym

Medrate; Medrol; Medrone; Urbason

Melting Point

228-237°C

Solubility

Slightly soluble in ethanol (10 mg/mL), dioxane, acetone, or chloroform. Insoluble in water.

Appearance

White to off white powder

Lu YS, Pu LY, Li XC, et al. Methylprednisolone inhibits activated CD4+ T cell survival promoted by toll-like receptor ligands. Hepatobiliary Pancreat Dis Int. 2010 Aug;9(4):376-83. PMID: 20688601.

Das A, Banik NL, Ray SK. Methylprednisolone and indomethacin inhibit oxidative stress mediated apoptosis in rat C6 glioblastoma cells. Neurochem Res. 2007 Nov;32(11):1849-56. PMID: 17570061.

Sloka JS, Stefanelli M. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler. 2005 Aug;11(4):425-32. PMID: 16042225.

1037624-75-2